Anabelle Sellame

Growth Strategy & Marketing Consultant | Pharma

Salaire / Taux journalier

Paris, France

Freelance, ouvert au CDI

Peut venir sur site

Expertises

Go-to-marketGestion de projet - PMOStratégie SalesStratégie MarketingBusiness DevelopmentStratégie ProduitProduct MarketingLinkedIn AdsHotjarKlaviyoMarketing OpsStratégie de marqueMeta AdsSalesforceMailChimpGoogle AnalyticsStratégie & ConsultingGrowthSEAÉvénementielLead NurturingGoogle AdsTikTok AdsActive CampaignComptabilitéProject OwnerFinanceEmailingSEOSocial Ads

Langues

AnglaisEspagnolFrançais

À propos

Introduction

Growth strategist & serial entrepreneur with 4+ years driving pharma/healthtech startups to success. Generated hundreds of thousands in revenue at Nootropia, secured $7M+ in funding across ventures, and led COVID mask launch contributing to IPO. Specialized in fundraising, Web3/AI strategy, and scaling operations for rapid market expansion.

Liens

Expérience de travail

Growth Strategy & Marketing Consultant | Pharma, Healthcare & Consumer Health

STRYKE

sept. 2023 - Présent

3 ans 2 mois

À distance

stryke-consulting.fr AstraZeneca, Naturavignon, Naos, DoryCare, DoryGo,... Delivered advisory services on digital marketing strategies to boost visibility and user engagement. Supported clients in restructuring and optimizing their operational models, as well as in developing investor relations, securing funding, and expanding their market presence through targeted business development initiatives. Assisted in the reorganization of governance structures to enhance decision-making efficiency and meet strategic goals. Played a key role in defining transformation roadmaps and ensuring the success of operational and market transitions.

Operating Member

Squaadra

déc. 2024 - Présent

1 an 11 mois

Squaadra is a collective of 25+ independent experts powered by Caleb ventures. We unite top advisors to deliver exceptional support to startups, scale-ups & SMEs. We are serial entrepreneurs, former C-levels, strategists and independent investment bankers. We provide actionable strategy, hands-on execution & a network that opens doors. We help you raise money, find new clients & accelerate your growth. - Fundraising - Deal making - Operating Partner

Co-founder

3615 future

oct. 2023 - oct. 2024

1 an 1 mois

Consulting and tech development firm focused on Web3 and AI. Led business development and secured strategic partnerships. Advised startups on project strategy, tokenomics, and go-to-market execution. Provided guidance on Web3 adoption, product positioning, and community building.

CEO - Founder

Nootropia

mars 2021 - mars 2024

3 ans 1 mois

Paris, France

Conceptualized, developed, and launched a patented 4-in-1 liquid food supplement, setting a new standard in the market. Built a dedicated community of 14,000 members in just six months and generated hundreds of thousands of euros in revenue during the first. Defined the business strategy, financial plan, and structured operations to support rapid, sustainable growth. Developed strong investor relations, securing fundings.

Co-Founder

Cryptoplanet

nov. 2020 - mai 2021

7 mois

Dapp in Solidity (ERC-721) Smart contracts on ethereum blockchain Crypto Planet was a DApp at the intersection of CryptoKitties (NFT game) and Forest (an app that allows you to stay focused that allowed you to "boost and fusion" your NFTs by spending focused time on important tasks of your everyday life.

Entrepreneur In Residence

HEC-42 Launchpad

janv. 2021 - mars 2021

3 mois

Paris, France

Elaboration of future food (proteins) based on algae -

Global Business Developer

betalin therapeutics

sept. 2019 - août 2020

1 an

Israelândia, GO, 76205-000, Brésil

Pharmaceutical company. Raised 2.2M$ non dilutive money from the European commission. Market Research & Expansion: Conducted in-depth market research to identify trends and opportunities, positioning the company as a leader in emerging technology solutions.

Global Business Developer

sonovia ltd

sept. 2019 - août 2020

1 an

Ramat Gan, Israël

Led the conceptualization and launch of an antiviral and antibacterial mask during the COVID-19 pandemic, which was instrumental in the company’s successful public listing within less than a year. Played a key role in the IPO as the first employee, identifying strategic market opportunities and forming collaborative partnerships. Managed investor relations, securing $5M in funding and overseeing due diligence.

Non resident Pharmacy student - microbiology laboratory

APHM (Assistance Publique - Hopitaux de Marseille)

sept. 2019 - mars 2020

7 mois

Marseille Area, France

- Working on a AI created to interpret Escherichia coli, Staphylococcus aureus, Klebsiella pneumoniae antibiograms (working in python and bash and incrementation of the database). - Creation of a new Pseudomonas aeruginosa database with two phenotypes for : the Top (Beta-lactams) and for the Bottom (Other antibiotics): "Wild" and "Other". --> 956 photos have been sort. - Implementation of this software on a new strain, namely Pseudomonas aeruginosa (P.aer).

Research assistant

Tel Aviv University

juil. 2019 - août 2019

2 mois

Tel-Aviv, Israël

Huntington disease, Influence of different treatment on PERK protein (involved in HD)


Formation

École Polytechnique

Msc X-HEC Entrepreneurs

2020 - 2021

2 ans

HEC Paris

Msc X-HEC Entrepreneurs

2020 - 2021

2 ans

Aix-Marseille University

2016 - 2021

6 ans

Université Côte d'Azur

Concours Première année commune d'étude de santé

2014 - 2016

3 ans

Portfolio

AstraZeneca

Le meilleur endroit pour trouver votre prochaine opportunité

© 2026. Tous droits réservés.